Satellos Bioscience Inc. (TSX:MSCL)

Satellos Bioscience Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.66	22.07	1.92	4.87	0.72
Short-Term Investments	12.2	17.52	-	-	-
Cash & Short-Term Investments	69.85	39.59	1.92	4.87	0.72
Cash Growth	76.46%	1957.54%	-60.50%	578.89%	79.77%
Other Receivables	0.63	0.58	0.26	0.53	0.41
Receivables	0.63	0.58	0.26	0.53	0.41
Prepaid Expenses	2.53	0.15	0.05	0.04	0
Other Current Assets	-	0	0	-	-
Total Current Assets	73.01	40.32	2.23	5.44	1.13
Property, Plant & Equipment	0.01	0.02	0.01	0.01	0
Long-Term Investments	-	0.04	0.04	-	-
Other Intangible Assets	-	3.92	3.92	7.14	-
Total Assets	73.02	44.3	6.2	12.59	1.13
Accounts Payable	2.97	1.04	1.47	1.13	0.13
Accrued Expenses	2.19	2.58	1.36	0.98	0.09
Total Current Liabilities	5.16	3.62	2.83	2.1	0.22
Long-Term Debt	-	-	-	-	1.09
Total Liabilities	5.16	3.62	2.83	2.1	1.31
Common Stock	105.73	61.92	30.21	28.32	4.36
Additional Paid-In Capital	10.33	8.5	3.69	1.24	0.25
Retained Earnings	-75.6	-47.5	-31.61	-20.29	-4.79
Comprehensive Income & Other	27.41	17.76	1.09	1.22	-
Shareholders' Equity	67.86	40.67	3.37	10.48	-0.18
Total Liabilities & Equity	73.02	44.3	6.2	12.59	1.13
Total Debt	-	-	-	-	1.09
Net Cash (Debt)	69.85	39.59	1.92	4.87	-0.38
Net Cash Growth	76.46%	1957.54%	-60.50%	-	-
Net Cash Per Share	0.61	0.46	0.05	0.20	-0.02
Filing Date Shares Outstanding	165.82	112.79	41.8	33	12.09
Total Common Shares Outstanding	165.82	112.79	41.8	33	12.09
Working Capital	67.86	36.7	-0.6	3.34	0.91
Book Value Per Share	0.41	0.36	0.08	0.32	-0.02
Tangible Book Value	67.86	36.76	-0.55	3.35	-0.18
Tangible Book Value Per Share	0.41	0.33	-0.01	0.10	-0.02
Machinery	-	-	0.01	0.01	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.